Hong-yu Li Institution-verified
Sourced from institutional research profiles (UAMS TRI or ARA).
Medicinal Chemistry
grad_student
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Hong-yu Li investigates molecular mechanisms of cancer, focusing on the development of novel therapeutic agents. His recent publication in 2026 explores an inhibitor for MV4-11 cells, examining its mechanism of action beyond FLT3 inhibition. Li is the Principal Investigator on a grant from the NIH/National Cancer Institute for the "Drug Development of Skp2 PROTACs in Cancer." This project aims to develop proteolysis-targeting chimeras (PROTACs) for Skp2, a protein implicated in various cancers.
Li is a member of the ARA Academy (ARA Scholar) and maintains an active laboratory website. His work contributes to the understanding of cancer-related molecular mechanisms and the advancement of pharmacological strategies for cancer treatment.
Metrics
- Publications: 1
Selected Publications
-
An unprecedented potent inhibitor of MV4-11 cells: investigations into the mechanism of action beyond FLT3 inhibition (2026)
ARA Academy 2016 ARA Scholar
Federal Grants 1 $1 total
Collaboration Network
Top Collaborators
- An unprecedented potent inhibitor of MV4-11 cells: investigations into the mechanism of action beyond FLT3 inhibition
- An unprecedented potent inhibitor of MV4-11 cells: investigations into the mechanism of action beyond FLT3 inhibition
- An unprecedented potent inhibitor of MV4-11 cells: investigations into the mechanism of action beyond FLT3 inhibition
- An unprecedented potent inhibitor of MV4-11 cells: investigations into the mechanism of action beyond FLT3 inhibition
Similar Researchers
Based on overlapping research topics